Alpha Profiles · Company Profile

Larimar Therapeutics, Inc.

Canonical company identity and public leadership record.

https://registry.alpha.ac/companies/larimar-therapeutics-inc

Entity: Public listing published
Primary listing: NASDAQ: LRMR
Verification: Partially verified
Last reviewed: 2026-10-27T04:46:45.069656+00:00

Overview

Alpha's canonical identity and public leadership record for Larimar Therapeutics, Inc..

Canonical AEGIS identity graph

Executive leadership

Current, confirmed roles are shown only when both the person Profile and supporting source record satisfy the public projection boundary. A missing role is not evidence that it does not exist.

Executive team

2 public records

Craig B. Thompson, M.D.

President and Chief Executive Officer

State: confirmed
Effective: From Apr 20, 2026
Confidence: 94%
Evidence: LRMR DEF 14A executive officersApr 20, 2026

Michael Celano

Chief Financial Officer

State: confirmed
Effective: From Apr 20, 2026
Confidence: 94%
Evidence: LRMR DEF 14A executive officersApr 20, 2026

Governance leadership

Boards & Committees

Board and committee assignments appear only when the canonical public projection retains a current role and supporting source. Unpublished records are not interpreted as absence.

Record as of Oct 27, 2026. Chair, executive office, Lead Independent Director and committee appointments retain their separate source roles. A complete board composition denominator and committee charters are not established by a partial roster.